| Financial toxicity in gynecologic oncology S Bouberhan, M Shea, A Kennedy, A Erlinger, H Stack-Dunnbier, ... Gynecologic oncology 154 (1), 8-12, 2019 | 96 | 2019 |
| Genomic aberrations in cervical adenocarcinomas in H ong K ong C hinese women TKH Chung, P Van Hummelen, PKS Chan, TH Cheung, SF Yim, MY Yu, ... International journal of cancer 137 (4), 776-783, 2015 | 96 | 2015 |
| The role of endometrial biopsy in the preoperative detection of uterine leiomyosarcoma EM Hinchcliff, KM Esselen, JC Watkins, T Oduyebo, JA Rauh-Hain, ... Journal of minimally invasive gynecology 23 (4), 567-572, 2016 | 76 | 2016 |
| Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England … R Vargas, LM Barroilhet, K Esselen, E Diver, M Bernstein, DP Goldstein, ... The Journal of reproductive medicine 59 (5-6), 188-194, 2014 | 74 | 2014 |
| Use of CA-125 tests and computed tomographic scans for surveillance in ovarian cancer KM Esselen, AM Cronin, K Bixel, MA Bookman, RA Burger, DE Cohn, ... JAMA oncology 2 (11), 1427-1433, 2016 | 56 | 2016 |
| Endosalpingiosis: more than just an incidental finding at the time of gynecologic surgery? KM Esselen, KL Terry, A Samuel, KM Elias, M Davis, WR Welch, MG Muto, ... Gynecologic oncology 142 (2), 255-260, 2016 | 50 | 2016 |
| Evaluating meaningful levels of financial toxicity in gynecologic cancers KMK Esselen, A Gompers, MR Hacker, S Bouberhan, M Shea, ... International Journal of Gynecologic Cancer 31 (6), 2021 | 44 | 2021 |
| Germline mutations of SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA4-deficient undifferentiated uterine sarcoma: Clinical features of a single … YD Connor, D Miao, DI Lin, C Hayne, BE Howitt, JL Dalrymple, ... Gynecologic oncology 157 (1), 106-114, 2020 | 37 | 2020 |
| Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review KM Esselen, DM Boruta, M Del Carmen, JO Schorge, A Goodman, ... International Journal of Gynecologic Cancer 21 (6), 2011 | 32 | 2011 |
| Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens KM Esselen, SK Ng, Y Hua, M White, CA Jimenez, WR Welch, R Drapkin, ... Gynecologic oncology 132 (2), 316-321, 2014 | 30 | 2014 |
| Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy KM Esselen, N Rodriguez, W Growdon, C Krasner, NS Horowitz, ... Gynecologic oncology 127 (1), 51-54, 2012 | 30 | 2012 |
| Health care disparities in hysterectomy for gynecologic cancers: data from the 2012 National Inpatient Sample KM Esselen, A Vitonis, J Einarsson, MG Muto, S Cohen Obstetrics & Gynecology 126 (5), 1029-1039, 2015 | 27 | 2015 |
| Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? EM Aviki, KM Esselen, SM Barcia, MR Nucci, NS Horowitz, CM Feltmate, ... Gynecologic oncology 137 (1), 60-65, 2015 | 26 | 2015 |
| Solitary fibrous tumor of the uterus presenting with lung metastases: a case report KC Strickland, MR Nucci, KM Esselen, MG Muto, S Chopra, S George, ... International journal of gynecological pathology 35 (1), 25-29, 2016 | 24 | 2016 |
| Crowdsourcing to measure financial toxicity in gynecologic oncology KM Esselen, H Stack-Dunnbier, A Gompers, MR Hacker Gynecologic oncology 161 (2), 595-600, 2021 | 19 | 2021 |
| Cost-effectiveness of cervical cancer prevention KM Esselen, S Feldman Clinical Obstetrics and Gynecology 56 (1), 55-64, 2013 | 19 | 2013 |
| Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer JA Rauh-Hain, SH Guseh, KM Esselen, WB Growdon, JO Schorge, ... International Journal of Gynecologic Cancer 23 (7), 2013 | 18 | 2013 |
| Adoption of enhanced recovery after laparotomy in gynecologic oncology AS Ore, MA Shear, FW Liu, JL Dalrymple, CS Awtrey, L Garrett, ... International Journal of Gynecologic Cancer 30 (1), 2020 | 17 | 2020 |
| Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer H Mahdi, A Gockley, K Esselen, J Marquard, B Nutter, B Yang, E Hinchcliff, ... Gynecologic oncology 139 (3), 407-412, 2015 | 16 | 2015 |
| What is the optimal treatment for obese patients with advanced ovarian carcinoma? MJ Worley Jr, SH Guseh, JA Rauh-Hain, KM Esselen, MG Muto, ... American journal of obstetrics and gynecology 211 (3), 231. e1-231. e9, 2014 | 16 | 2014 |
